Authors: Koppenhagen, FJ Balemans, LTM Steerenberg, PA Jagmont, TM Den Otter, W Storm, G

Citation: Fj. Koppenhagen et al., The design of a pharmaceutically acceptable liposomal formulation of recombinant interleukin-2 (rIL-2) for locoregional anticancer immunotherapy, J LIPOS RES, 9(3), 1999, pp. 313-329